Journey Medical (DERM) Operating Expenses (2020 - 2026)

Journey Medical's Operating Expenses history runs 7 years deep, the most recent figure standing at $17.5 million for Q1 2026.

• Quarterly Operating Expenses rose 6.01% year-over-year to $17.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.0 million (up 12.46% YoY) and the FY2025 annual result came in at $70.0 million, changed 0.31% from the prior year.
• Operating Expenses was $17.5 million for Q1 2026 at Journey Medical, up from $16.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $26.0 million in Q4 2022 and bottomed at $11.4 million in Q4 2024.
• A 5-year average of $20.0 million and a median of $17.9 million in 2025 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses jumped 138.64% — and 2024, when it sank 34.42%.
• Journey Medical's Operating Expenses stood at $26.0 million in 2022, then tumbled by 33.13% to $17.4 million in 2023, then sank by 34.42% to $11.4 million in 2024, then jumped by 45.11% to $16.5 million in 2025, then rose by 5.63% to $17.5 million in 2026.
• Business Quant data shows DERM's Operating Expenses at $17.5 million in Q1 2026, $16.5 million in Q4 2025, and $19.2 million in Q3 2025.